Cargando…

Macrophage Mineralocorticoid Receptor Is a Pleiotropic Modulator of Myocardial Infarct Healing

Myocardial infarction (MI) is a major cause of death worldwide. Here, we identify the macrophage MR (mineralocorticoid receptor) as a crucial pathogenic player in cardiac wound repair after MI. Seven days after left coronary artery ligation, mice with myeloid cell–restricted MR deficiency compared w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fraccarollo, Daniela, Thomas, Svenja, Scholz, Claus-Jürgen, Hilfiker-Kleiner, Denise, Galuppo, Paolo, Bauersachs, Johann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott, Williams & Wilkins 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291261/ https://www.ncbi.nlm.nih.gov/pubmed/30543467 http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12162

Ejemplares similares

Efficacy of mineralocorticoid receptor antagonism in the acute myocardial infarction phase: eplerenone versus spironolactone
por: Fraccarollo, Daniela, et al.
Publicado: (2015)

The glucocorticoid receptor in monocyte-derived macrophages is critical for cardiac infarct repair and remodeling
por: Galuppo, Paolo, et al.
Publicado: (2017)

Genetic ablation of fibroblast activation protein alpha attenuates left ventricular dilation after myocardial infarction
por: Hoffmann, Daniel B., et al.
Publicado: (2021)

Expansion of CD10(neg) neutrophils and CD14(+)HLA-DR(neg/low) monocytes driving proinflammatory responses in patients with acute myocardial infarction
por: Fraccarollo, Daniela, et al.
Publicado: (2021)

Breastfeeding in Patients With Heart Failure: Lack of Evidence and Consensus
por: Koenig, Tobias, et al.
Publicado: (2019)

Intermediate CD14(++)CD16(+) monocytes decline after transcatheter aortic valve replacement and correlate with functional capacity and left ventricular systolic function
por: Neuser, Jonas, et al.
Publicado: (2017)

5-Lipoxygenase facilitates healing after myocardial infarction
por: Blömer, Nadja, et al.
Publicado: (2013)

Peripartum cardiomyopathy: current management and future perspectives
por: Hilfiker-Kleiner, Denise, et al.
Publicado: (2015)

Characterization of peripartum cardiomyopathy by cardiovascular magnetic resonance imaging
por: Haghikia, Arash, et al.
Publicado: (2015)

Emerging translational approaches to target STAT3 signalling and its impact on vascular disease
por: Dutzmann, Jochen, et al.
Publicado: (2015)

Post-infarct remodelling: contribution of wound healing and inflammation
por: Frantz, Stefan, et al.
Publicado: (2009)

Increased Cytochrome P4502E1 Expression and Altered Hydroxyeicosatetraenoic Acid Formation Mediate Diabetic Vascular Dysfunction: Rescue by Guanylyl-Cyclase Activation
por: Schäfer, Andreas, et al.
Publicado: (2010)

Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
por: Agarwal, Rajiv, et al.
Publicado: (2020)

Peripartum cardiomyopathy
por: Koenig, T., et al.
Publicado: (2018)

Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2022)

Reduction of Myocardial Infarct Size by Dronedarone in Pigs—A Pleiotropic Action?
por: Skyschally, Andreas, et al.
Publicado: (2011)

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2021)

Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure
por: Löfman, Ida, et al.
Publicado: (2018)

Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure
Publicado: (2019)

Impact of mineralocorticoid receptor gene NRC2 on the prediction of arrhythmia after acute myocardial infarction
por: Daniulaityte, K, et al.
Publicado: (2023)

Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion
por: Boengler, Kerstin, et al.
Publicado: (2010)

Macrophage-driven cardiac inflammation and healing: insights from homeostasis and myocardial infarction
por: Zuo, Wenjie, et al.
Publicado: (2023)

The Nitric Oxide Donor Pentaerythritol Tetranitrate Reduces Platelet Activation in Congestive Heart Failure
por: Flierl, Ulrike, et al.
Publicado: (2015)

Retrospective review of in hospital use of mineralocorticoid receptor antagonists for high risk patients following myocardial infarction
por: Miller, Robert J. H., et al.
Publicado: (2015)

Behavioral pathway to a broken heart: The link between adverse childhood experiences, depression, physical exercise and cardiovascular health
por: Bertele, Sebastian, et al.
Publicado: (2022)

The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury
por: Dutzmann, Jochen, et al.
Publicado: (2017)

YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction
por: Mia, Masum M., et al.
Publicado: (2020)

Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy
por: Haghikia, Arash, et al.
Publicado: (2015)

Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study
por: Haghikia, Arash, et al.
Publicado: (2015)

High prevalence of reduced fertility and use of assisted reproductive technology in a German cohort of patients with peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2022)

Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies
por: Frantz, Stefan, et al.
Publicado: (2022)

Activation of E-prostanoid 3 receptor in macrophages facilitates cardiac healing after myocardial infarction
por: Tang, Juan, et al.
Publicado: (2017)

Mineralocorticoid receptor deficiency improves the therapeutic effects of mesenchymal stem cells for myocardial infarction via enhanced cell survival
por: Xie, Xinxing, et al.
Publicado: (2018)

Predictors of the Use of Mineralocorticoid Receptor Antagonists in Patients With Left Ventricular Dysfunction Post‐ST‐Segment–Elevation Myocardial Infarction
por: Wong, Eric C., et al.
Publicado: (2021)

Multimodal MRI in the course of cardiac wound healing after myocardial infarction
por: Bönner, Florian, et al.
Publicado: (2012)

Antiinfective and wound-healing pleiotropic actions of Ankaferd hemostat
por: HAZNEDAROĞLU, İbrahim Celalettin, et al.
Publicado: (2020)

Will Ticagrelor Help Post-Myocardial Infarction ‘Healing’?
por: Park, Kyung Woo
Publicado: (2019)

The cardiac wound healing response to myocardial infarction
por: Chalise, Upendra, et al.
Publicado: (2022)

Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy
por: Hoch, Melanie, et al.
Publicado: (2011)

Kardiologie: Grenzen überwinden, neue Welten entdecken
por: Hilfiker-Kleiner, Denise, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eqrm8eqlthmg502b99q68f831t